Natalia Pociej

Natalia Pociej

Auto-generated profile, based on publicly available information

Natalia Pociej

Pomeranian Medical University in Szczecin, Poland Rybacka 1, 70-204 Szczecin

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
APAleksandra Iga Pociej
Aleksandra Iga Pociej
NPNatalia Pociej
Natalia Pociej
KDKrzysztof Dzierbunowicz
Krzysztof Dzierbunowicz
WPWojciech Pociej
Wojciech Pociej
Background: Reconstructive surgery following mastectomy has shifted from traditional subpectoral breast reconstruction (SBR) toward muscle-sparing prepectoral breast reconstruction (PBR). Aim: This review aims to systematically compare the aesthetic outcomes, surgical complication rates, and patient-reported quality of life between PBR and SBR. Materials and Methods: A systematic literature search was conducted across PubMed and Scopus databases (2021- 2026) in accordance with PRISMA guidelines. Out of 629 initial records, 27 full-text comparative reviews involving human subjects were selected for qualitative synthesis. Results: Overall major complication rates and long-term implant survival were comparable between the two methods. SBR offered greater structural coverage, reducing implant rippling and wound dehiscence. However, PBR significantly reduced early postoperative pain, opioid consumption, and eliminated animation deformity. Patients undergoing PBR reported higher satisfaction in psychosocial and sexual well-being (BREAST-Q). Both methods demonstrated equivalent safety during postmastectomy radiotherapy. Conclusions: Neither technique is universally superior. PBR is a highly effective, muscle-sparing alternative that optimizes recovery and dynamic aesthetics, provided there is adequate skin flap perfusion. SBR remains a reliable option for compromised tissue coverage.

7 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JKJęDrzej Kowalski
JęDrzej Kowalski
DSDominik Szymczak
Dominik Szymczak
OZOlaf Zołotar
Olaf Zołotar
MSMarcin Szczepanik
Marcin Szczepanik
NPNatalia Pociej
Natalia Pociej
KDKrzysztof Dzierbunowicz
Krzysztof Dzierbunowicz
Background: Antibody-drug conjugates (ADC) are a promising novel therapy for oncology patients as it combines tumor- targeted antibodies with cytotoxic molecules resulting in improved therapeutic outcomes. Aim: The aim of this article is a thorough analysis of ADC possibilities in oncology focusing on treatment options, side effects of therapies for breast, bladder and lung cancers. Material and methods: A search of relevant research databases was conducted to identify eligible papers. Results: Findings reveal ADC to be a promising treatment option as a innovative, more precise form of therapy.